CovR mediated antibiofilm activity of 3-furancarboxaldehyde increases the virulence of group a streptococcus

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Subramenium, Ganapathy Ashwinkumar ^a   Viszwapriya, Dharmaprakash ^a   Iyer, Prasanth Mani ^a   Balamurugan, Krishnaswamy ^a   Pandian, Shunmugiah Karutha ^a  

^a ALAGAPPA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

3 FURANCARBOXALDEHYDE; ALDEHYDE; HYALURONIC ACID; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; CSRR PROTEIN, STREPTOCOCCUS PYOGENES; PLANT EXTRACT; REPRESSOR PROTEIN; VOLATILE ORGANIC COMPOUND;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BIOFILM; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; COVR GENE; DOWN REGULATION; GENE OVEREXPRESSION; HASA GENE; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; LUXS GENE; MGA GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SRTB GENE; SRV GENE; STREPTOCOCCUS GROUP A; ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MICROBIOLOGY; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; VIRULENCE;

CAENORHABDITIS ELEGANS; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A';

ANIMALS; BACTERIAL PROTEINS; BIOFILMS; CAENORHABDITIS ELEGANS; DOWN-REGULATION; DRUG RESISTANCE, MICROBIAL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; PLANT EXTRACTS; REPRESSOR PROTEINS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VIRULENCE; VOLATILE ORGANIC COMPOUNDS;

EID: 84929379668     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0127210     Document Type: Article

References (54)

1. CunninghamMW (2000). Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13: 470-511. PMID: 10885988
2. Kim S, Lee NY (2004) Epidemiology and antibiotic resistance of group A streptococci isolated from healthy school children in Korea. J Antimicrob Chemoth 54: 447-450.
3. Krzysciak W, Pluskwa KK, Jurczak A, Koscielniak D (2013) The pathogenicity of the Streptococcus genus. Eur J Clin Microbiol Infect Dis 32: 1361-1376. doi: 10.1007/s10096-013-1914-9 PMID: 24141975
4. Lembke C, Podbielski A, Hidalgo-Grass C, Jonas L, Hanski E, Kreikemeyer B (2006) Characterization of biofilm formation by clinically relevant serotypes of group A streptococci. Appl Environ Microbiol 72: 2864-2875. PMID: 16597993
5. Bugrysheva JV, Scott JR (2010) Regulation of virulence gene expression in Streptococcus pyogenes. RNA Biol 7: 569-572. PMID: 21037420
6. Terao Y (2012). The virulence factors and pathogenic mechanisms of Streptococcus pyogenes. J Oral Biosci 54: 96-100.
7. Hall-Stoodley L, Costerton JW, Stoodley P (2004) Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2: 95-108. PMID: 15040259
8. Davies D (2003) Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discovery 2: 114-122. PMID: 12563302
9. Conley J, Olson ME, Cook LS, Ceri H, Phan V, Davies HD (2003) Biofilm formation by group a streptococci: is there a relationship with treatment failure? J Clin Microbiol 41: 4043-4048. PMID: 12958223
10. Seppala H, Nissinen A, Jarvinen H, Huovinen S, Henriksson T, Herva E, et al. (1992) Resistance to erythromycin in group A streptococci. N Engl J Med 326: 292-297. PMID: 1728733
11. York MK, Gibbs L, Perdreau-Remington F, Brooks GF (1999) Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of Northern California. J Clin Microbiol 37: 1727-1731. PMID: 10325315
12. Perez-Trallero E, Marimón JM, Montes M, Orden B, de Pablos M (1999) Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain. Emerg Infect Dis 5: 235-240. PMID: 10221875
13. Lembke C, Podbielski A, Hidalgo-Grass C, Jonas L, Hanski E, Kreikemeyer B (2006) Characterization of biofilm formation by clinically relevant serotypes of group A streptococci. Appl Environ Microbiol 72: 2864-2875. PMID: 16597993
14. Thenmozhi R, Balaji K, Kumar R, Rao TS, Pandian SK (2011) Characterization of biofilms in different clinical M serotypes of Streptococcus pyogenes. J Basic Microbiol 51: 196-204. doi: 10.1002/jobm. 201000006 PMID: 21298675
15. Baldassarri L, Creti R, Recchia S, Imperi M, Facinelli B, Giovanetti E, et al. (2006) Therapeutic failures of antibiotics used to treat macrolide-susceptible Streptococcus pyogenes infections may be due to biofilm formation. J Clin Microbiol 44: 2721-2727. PMID: 16891483
16. Roberts AL, Connolly KL, Kirse DJ, Evans AK, Poehling KA, Peters TR, et al. (2012) Detection of group A Streptococcus in tonsils from pediatric patients reveals high rate of asymptomatic streptococcal carriage. BMC Pediatr 12: 3. doi: 10.1186/1471-2431-12-3 PMID: 22230361
17. Torretta S, Marchisio P, Drago L, Baggi E, De VE, GaravelloW, et al. (2012) Nasopharyngeal biofilmproducing otopathogens in children with non severe recurrent acute otitis media. Otolaryngol.Head Neck Surg 146: 991-996. doi: 10.1177/0194599812438169 PMID: 22357644
18. Hoch JA (2000) Two-component and phosphorelay signal transduction. Curr Opin Microbiol 3: 165-170. PMID: 10745001
19. Kreikemeyer B, McIver KS, Podbielski A (2003) Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen-host interactions. Trends Microbiol 11: 224-232. PMID: 12781526
20. Fiedler T, Sugareva V, Patenge N, Kreikemeyer B (2010) Insights into Streptococcus pyogenes pathogenesis from transcriptome studies. Future Microbiol 5: 1675-1694. doi: 10.2217/fmb.10.128 PMID: 21133689
21. Patenge N, Fiedler T, Kreikemeyer B (2013) Common regulators of virulence in streptococci. In Host-Pathogen Interactions in Streptococcal Diseases (pp. 111-153). Springer Berlin Heidelberg. doi: 10. 1007/82-2012-296 PMID: 23212184
22. Nozal MJ, Bernal JL, Toribio L, Jiménez JJ, Marti'n MT (2001) High-performance liquid chromatographic determination of methyl anthranilate, hydroxymethylfurfural and related compounds in honey. J Chromatogr A 917: 95-103. PMID: 11403496
23. Lin P, Cai J, Li J, Sang W, Su Q (2003) Constituents of the essential oil of Hemerocallis flava day lily. Flavour Frag J 18: 539-541.
24. Bianchi F, Careri M, Musci M (2005) Volatile norisoprenoids as markers of botanical origin of Sardinian strawberry-tree (Arbutus unedo L.) honey: Characterisation of aroma compounds by dynamic headspace extraction and gas chromatography-mass spectrometry. Food chem 89: 527-532.
25. Hasan S, Danishuddin M, Adil M, Singh K, Verma PK, Khan AU (2012) Efficacy of E. officinalis on the cariogenic properties of Streptococcus mutans: a novel and alternative approach to suppress quorumsensing mechanism. PLOS ONE 7: e40319. doi: 10.1371/journal.pone.0040319 PMID: 22792279
26. Pino J, Marbot R, Vázquez C (2004) Volatile components of the fruits of Vangueria madagascariensis JF Gmel. from Cuba. J Essent Oil Res 16: 302-304.
27. Benyelles B, Allali H, El Amine Dib M, Djabou N, Tabti B, Costa J (2011) Essential oil from Rhaponticum acaule L. roots: Comparative study using HS-SPME/GC/GC-MS and hydrodistillation techniques. J Saudi Chem Soc 18: 972-976.
28. Tan JJ, Azmi SM, Yong YK, Cheah HL, Lim V, Sandai D, et al. (2014) Tualang Honey Improves Human Corneal Epithelial Progenitor Cell Migration and Cellular Resistance to Oxidative Stress In Vitro. PLOS ONE 9: e96800. doi: 10.1371/journal.pone.0096800 PMID: 24802273
29. Darmstadt GL, Mentele L, Podbielski A, Rubens CE (2000) Role of group A streptococcal virulence factors in adherence to keratinocytes. Infect Immun 68: 1215-1221. PMID: 10678929
30. Landini P, Antoniani D, Burgess JG, Nijland R (2010) Molecular mechanisms of compounds affecting bacterial biofilm formation and dispersal. Appl Microbiol Biotechnol 86: 813-823. doi: 10.1007/s00253-010-2468-8 PMID: 20165945
31. Wilson AT (1959) The relative importance of the capsule and the M-antigen in determining colony form of group A streptococci. J Exp Med 109: 257-270. PMID: 13620853
32. Moses AE, Wessels MR, Zalcman K, Albertí S, Natanson-Yaron S, Menes T, et al. (1997) Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus. Infect Immun 65: 64-71. PMID: 8975893
33. Ribardo DA, Lambert TJ, McIver KS (2004) Role of Streptococcus pyogenes two-component response regulators in the temporal control of Mga and the Mga-regulated virulence gene emm. Infect Immun 72: 3668-3673. PMID: 15155682
34. Schmidt KH, Gunther E, Courtney HS (1996) Expression of both M protein and hyaluronic acid capsule by group A streptococcal strains results in a high virulence for chicken embryos. Med Microbiol Immun 184: 169-17. PMID: 8811648
35. Cleary PP, Larkin A (1979) Hyaluronic acid capsule: strategy for oxygen resistance in group A streptococci. J Bacteriol 140: 1090-1097. PMID: 391798
36. Green AE, Rowlands RS, Cooper RA, Maddocks SE (2012) The effect of the flavonol morin on adhesion and aggregation of Streptococcus pyogenes. FEMS Microbiol Lett 333: 54-58. doi: 10.1111/j. 1574-6968.2012.02598.x PMID: 22591139
37. Kang SO, Wright JO, Tesorero RA, Lee H, Beall B, Cho KH (2012) Thermoregulation of capsule production by Streptococcus pyogenes. PLOS ONE 7: e37367. doi: 10.1371/journal.pone.0037367 PMID: 22615992
38. Mayfield JA, Liang Z, Agrahari G, Lee SW, Donahue DL, Ploplis VA, et al. (2014) Mutations in the control of virulence sensor gene from Streptococcus pyogenes after infection in mice lead to clonal bacterial variants with altered gene regulatory activity and virulence. PLOS ONE 9: e100698. doi: 10.1371/journal.pone.0100698 PMID: 24968349
39. Kreth J, Chen Z, Ferretti J, Malke H (2011) Counteractive balancing of transcriptome expression involving CodY and CovRS in Streptococcus pyogenes. J Bacteriol 193: 4153-4165. doi: 10.1128/JB. 00061-11 PMID: 21705595
40. Gryllos I, Levin JC, Wessels MR (2003) The CsrR/CsrS two-component system of group A Streptococcus responds to environmental Mg2+. P Natl Acad Sci 100: 4227-4232. PMID: 12646707
41. Dalton TL, Collins JT, Barnett TC, Scott JR (2006) RscA, a member of the MDR1 family of transporters, is repressed by CovR and required for growth of Streptococcus pyogenes under heat stress. J Bacteriol 188: 77-85. PMID: 16352823
42. Graham MR, Smoot LM, Migliaccio CAL, Virtaneva K, Sturdevant DE, Porcella SF, et al. (2002). Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. P Natl Acad Sci 99: 13855-13860. PMID: 12370433
43. Cho KH, Caparon M G (2005) Patterns of virulence gene expression differ between biofilm and tissue communities of Streptococcus pyogenes. Mol Microbiol 57: 1545-1556. PMID: 16135223
44. Roberts SA, Scott JR (2007) RivR and the small RNA RivX: the missing links between the CovR regulatory cascade and the Mga regulon. Mol Microbiol 66: 1506-1522. PMID: 18005100
45. Heath A, DiRita VJ, Barg NL, Engleberg NC (1999) A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B. Infect Immun 67: 5298-5305. PMID: 10496909
46. Levin JC, Wessels MR (1998) Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus. Mol Microbiol 30: 209-219. PMID: 9786197
47. Marouni MJ, Sela S (2003) The luxS gene of Streptococcus pyogenes regulates expression of genes that affect internalization by epithelial cells. Infect Immun 71: 5633-5639. PMID: 14500483
48. Caparon MG, Scott JR (1987) Identification of a gene that regulates expression of M protein, the major virulence determinant of group A streptococci. P Natl Acad Sci 84: 8677-8681. PMID: 2446327
49. Engleberg NC, Heath A, Vardaman K, DiRita VJ (2004) Contribution of CsrR-regulated virulence factors to the progress and outcome of murine skin infections by Streptococcus pyogenes. Infect Immun 72: 623-628. PMID: 14742501
50. Doern CD, Roberts AL, Hong W, Nelson J, Lukomski S, Swords WE, et al. (2009) Biofilm formation by group A Streptococcus: a role for the streptococcal regulator of virulence (Srv) and streptococcal cysteine protease (SpeB). Microbiol 155: 46-52.
51. Tatsuno I, Isaka M, Okada R, Zhang Y, Hasegawa T (2014) Relevance of the two-component sensor protein CiaH to acid and oxidative stress responses in Streptococcus pyogenes. BMC Res Notes 7: 189. doi: 10.1186/1756-0500-7-189 PMID: 24673808
52. Kimura KR, Nakata M, Sumitomo T, Kreikemeyer B, Podbielski A, Terao Y, et al. (2012) Involvement of T6 pili in biofilm formation by serotype M6 Streptococcus pyogenes. J Bacteriol 194: 804-812. doi: 10. 1128/JB.06283-11 PMID: 22155780
53. Dengg M, van Meel JC (2004) Caenorhabditis elegans as model system for rapid toxicity assessment of pharmaceutical compounds. J Pharmacol Toxicol Methods 50: 209-214. PMID: 15519907
54. Leung MCK, Williams PL, Benedetto A, Au C, Helmcke KJ, Aschner M, et al. (2008). Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology. Toxicol Sci 106: 5-28. doi: 10.1093/toxsci/kfn121 PMID: 18566021